Arthur T. Sands
2009 - Lexicon Pharmaceuticals
In 2009, Arthur T. Sands earned a total compensation of $1.8M as President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $210,000 |
|---|---|
| Option Awards | $841,263 |
| Salary | $560,000 |
| Stock Awards | $149,930 |
| Other | $6,965 |
| Total | $1,768,158 |
Sands received $841.3K in option awards, accounting for 48% of the total pay in 2009.
Sands also received $210K in bonus, $560K in salary, $149.9K in stock awards and $7K in other compensation.
Rankings
In 2009, Arthur T. Sands' compensation ranked 2,715th out of 9,885 executives tracked by ExecPay. In other words, Sands earned more than 72.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,715 out of 9,885 | 73rd |
Division Manufacturing | 951 out of 3,690 | 74th |
Major group Chemicals And Allied Products | 186 out of 866 | 79th |
Industry group Drugs | 111 out of 638 | 83rd |
Industry Pharmaceutical Preparations | 88 out of 446 | 80th |
Source: SEC filing on March 16, 2012.
Sands' colleagues
We found five more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2009.
2009
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2009
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2009
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
2009
Ajay Bansal
Lexicon Pharmaceuticals
Chief Financial Officer
2009
James Tessmer
Lexicon Pharmaceuticals
Vice President, Finance and Accounting
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021